Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001140361-26-035613 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 3, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
487,815
Total Value
$185,707.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Sep 2, 2026 | Sale to Issuer | 1,375 | $135.06 | $185,707.50 | 167,123 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 3, 2026 | Sale to Issuer | 167,123 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Sep 3, 2026 | Sale to Issuer | 110,665 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Sep 3, 2026 | Sale to Issuer | 124,962 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Sep 3, 2026 | Sale to Issuer | 83,690 | โ | โ | 0 | Direct | โ | View Details |